Correlation Between Lucy Scientific and Petros Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Lucy Scientific and Petros Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lucy Scientific and Petros Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lucy Scientific Discovery and Petros Pharmaceuticals, you can compare the effects of market volatilities on Lucy Scientific and Petros Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lucy Scientific with a short position of Petros Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lucy Scientific and Petros Pharmaceuticals.
Diversification Opportunities for Lucy Scientific and Petros Pharmaceuticals
0.31 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Lucy and Petros is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Lucy Scientific Discovery and Petros Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Petros Pharmaceuticals and Lucy Scientific is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lucy Scientific Discovery are associated (or correlated) with Petros Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Petros Pharmaceuticals has no effect on the direction of Lucy Scientific i.e., Lucy Scientific and Petros Pharmaceuticals go up and down completely randomly.
Pair Corralation between Lucy Scientific and Petros Pharmaceuticals
Given the investment horizon of 90 days Lucy Scientific Discovery is expected to generate 5.23 times more return on investment than Petros Pharmaceuticals. However, Lucy Scientific is 5.23 times more volatile than Petros Pharmaceuticals. It trades about 0.08 of its potential returns per unit of risk. Petros Pharmaceuticals is currently generating about 0.01 per unit of risk. If you would invest 2,990 in Lucy Scientific Discovery on August 28, 2024 and sell it today you would lose (2,988) from holding Lucy Scientific Discovery or give up 99.93% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 82.56% |
| Values | Daily Returns |
Lucy Scientific Discovery vs. Petros Pharmaceuticals
Performance |
| Timeline |
| Lucy Scientific Discovery |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Petros Pharmaceuticals |
Lucy Scientific and Petros Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lucy Scientific and Petros Pharmaceuticals
The main advantage of trading using opposite Lucy Scientific and Petros Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lucy Scientific position performs unexpectedly, Petros Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Petros Pharmaceuticals will offset losses from the drop in Petros Pharmaceuticals' long position.| Lucy Scientific vs. Shuttle Pharmaceuticals | Lucy Scientific vs. Lifecore Biomedical | Lucy Scientific vs. Journey Medical Corp | Lucy Scientific vs. Akanda Corp |
| Petros Pharmaceuticals vs. Eliem Therapeutics | Petros Pharmaceuticals vs. Scpharmaceuticals | Petros Pharmaceuticals vs. Milestone Pharmaceuticals | Petros Pharmaceuticals vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |